Informações:
Falhas:
ID
14295
Descrição
Cell Biology of Steroid Resistant Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00361920
Link
https://clinicaltrials.gov/show/NCT00361920
Palavras-chave
Versões (1)
- 07/04/2016 07/04/2016 -
Titular dos direitos
CC BY-NC 3.0
Transferido a
7 de abril de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Asthma NCT00361920
Eligibility Asthma NCT00361920
- StudyEvent: Eligibility
Similar models
Eligibility Asthma NCT00361920
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
asthma
Item
1. will meet american thoracic society criteria for asthma
boolean
C0004096 (UMLS CUI [1])
fev1
Item
2. pulmonary function tests consistent with asthma. this includes a baseline fev1 < 80% predicted as well as a 12% improvement in fev1 following up to 4 puffs of albuterol.
boolean
C0748133 (UMLS CUI [1])
C0001927 (UMLS CUI [2])
C0001927 (UMLS CUI [2])
age
Item
3. subjects must be 12 to 65 years old.
boolean
C0001779 (UMLS CUI [1])
viral infection
Item
1. viral infection within four weeks of the starting date.
boolean
C0009450 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
hepatic function
Item
2. abnormal hepatic function.
boolean
C0232741 (UMLS CUI [1])
copd
Item
3. history of copd
boolean
C0024117 (UMLS CUI [1])
pregnancy
Item
4. pregnancy.
boolean
C0032961 (UMLS CUI [1])
history of smoking
Item
5. history of smoking.
boolean
C1519384 (UMLS CUI [1])
anemia
Item
6. anemia (hemoglobin less than 12 gm %)
boolean
C0002871 (UMLS CUI [1])
anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone
Item
7. concurrent therapy with anticonvulsants, erythromycin, rifampin and any systemic asthma medication including singular®, xolair® or oral prednisone.
boolean
C0003286 (UMLS CUI [1])
C0014806 (UMLS CUI [2])
C0035608 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
C0205373 (UMLS CUI [4,3])
C1174773 (UMLS CUI [5])
C3216040 (UMLS CUI [6])
C0014806 (UMLS CUI [2])
C0035608 (UMLS CUI [3])
C0013227 (UMLS CUI [4,1])
C0004096 (UMLS CUI [4,2])
C0205373 (UMLS CUI [4,3])
C1174773 (UMLS CUI [5])
C3216040 (UMLS CUI [6])
inhaled corticosteroids
Item
8. greater than 500 mcg per day of inhaled corticosteroids
boolean
C2065041 (UMLS CUI [1])
non-compliance with medical care
Item
9. suspected non-compliance with medical care.
boolean
C1321605 (UMLS CUI [1])
abnormal prednisone pharmacokinetics
Item
10. abnormal prednisone pharmacokinetics (applies to phase 2 of trial)
boolean
C0032952 (UMLS CUI [1,1])
C0031327 (UMLS CUI [1,2])
C0031327 (UMLS CUI [1,2])
comorbidity limiting participation
Item
11. patients with severe medical conditions that in the view of the investigator prohibits participation in the study (specify as required)
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
investigational agent
Item
12. use of any investigational agent in the last 30 days
boolean
C1875319 (UMLS CUI [1])